Claritev Corporation (CTEV) vs National Research Corporation (NRC)
- Claritev Corporation CTEV 22.88 +13.16%
- National Research Corporation NRC 25.83 +1.37%
Claritev Corporation and National Research Corporation are both Health Information Services companies. National Research Corporation is the larger, with a market value of $563.6M against $342.7M — 1.6× the size. Claritev Corporation has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 90.2×. Claritev Corporation grew revenue faster over the last twelve months: 6.32% against 3.37%. National Research Corporation has the higher net margin (4.26% vs −28.5%) and the higher return on invested capital (11.6% vs 0.47%). Across the 19 metrics below, National Research Corporation leads on 10 and Claritev Corporation on 9.
Valuation
Profitability
| Metric | CTEV | NRC | Health Information Services median |
|---|---|---|---|
| Gross margin | 72.97% | 60.69% | 59.61% |
| Operating margin | 3.27% | 11.06% | (10.54%) |
| Net margin | (28.46%) | 4.26% | (16.14%) |
| Free cash flow margin | (1.80%) | 12.83% | 0.00% |
| Return on equity | 172.76% | 236.21% | (3.15%) |
| Return on assets | (5.76%) | 4.46% | (5.62%) |
| Return on invested capital | 0.47% | 11.64% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack